Michael Buhle
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Michael Buhle is President & Chief Executive Officer at Aspira Women's Health, Inc. since 2025.
Formerly, Mr. Buhle was Chief Commercial Officer at Biovision Diagnostics LLC from 2022 to 2024 and Vice President-Sales & Americas at Congenica Ltd. Mr. Buhle completed undergraduate studies at the University of Clarke.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Vorstandsvorsitzender | 21.02.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Biovision Diagnostics LLC
Biovision Diagnostics LLC Medical/Nursing ServicesHealth Services Provides laboratory services | Corporate Officer/Principal | 01.12.2024 |
Congenica Ltd.
Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Aspira Women's Health, Inc.
Aspira Women's Health, Inc. BiotechnologyHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
University of Clarke
University of Clarke Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Congenica Ltd.
Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Technology Services |
Biovision Diagnostics LLC
Biovision Diagnostics LLC Medical/Nursing ServicesHealth Services Provides laboratory services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen